An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy

Am J Cardiol. 1995 Apr 15;75(12):853-4. doi: 10.1016/s0002-9149(99)80432-9.

Authors

M R Mehra¹, H O Ventura, F W Smart, T J Collins, S R Ramee, D D Stapleton

Affiliation

¹ Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, Louisiana 70121, USA.

PMID: 7717300
DOI: 10.1016/s0002-9149(99)80432-9

No abstract available

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Calcium Channel Blockers / therapeutic use*
Captopril / therapeutic use
Coronary Disease / diagnostic imaging
Coronary Disease / pathology
Coronary Disease / prevention & control*
Diltiazem / therapeutic use
Enalapril / therapeutic use
Female
Heart Transplantation / adverse effects
Heart Transplantation / diagnostic imaging*
Heart Transplantation / pathology
Humans
Hyperplasia
Lisinopril / therapeutic use
Male
Middle Aged
Nifedipine / therapeutic use
Transplantation, Homologous
Tunica Intima / drug effects
Tunica Intima / pathology
Ultrasonography, Interventional*
Verapamil / therapeutic use

Substances

Angiotensin-Converting Enzyme Inhibitors
Calcium Channel Blockers
Enalapril
Captopril
Verapamil
Lisinopril
Diltiazem
Nifedipine